Protein Name |
Pfam ID |
Percentage of Identity (%) |
E value |
Mixed lineage kinase 1 (MAP3K9)
|
|
32.441 (97/299) |
5.88E-33 |
Salt-inducible kinase 2 (SIK2)
|
|
31.163 (67/215) |
6.00E-24 |
Serine/threonine-protein kinase 26 (STK26)
|
|
30.469 (78/256) |
7.95E-24 |
Serine/threonine-protein kinase 25 (STK25)
|
|
29.478 (79/268) |
1.67E-23 |
Putative serine/threonine-protein kinase SIK1B (SIK1B)
|
|
31.797 (69/217) |
2.80E-23 |
Serine/threonine-protein kinase ULK2 (ULK2)
|
|
31.731 (66/208) |
2.87E-23 |
Salt-inducible kinase 1 (SIK1)
|
|
31.797 (69/217) |
2.95E-23 |
Serine/threonine-protein kinase 24 (STK24)
|
|
29.412 (80/272) |
6.42E-23 |
Ste-20-related kinase (STK39)
|
|
27.612 (74/268) |
7.72E-23 |
Oxidative stress responsive 1 (OXSR1)
|
|
27.046 (76/281) |
1.16E-22 |
Serine/threonine-protein kinase ULK1 (ULK1)
|
|
31.100 (65/209) |
2.89E-22 |
Microtubule affinity regulating kinase 3 (MARK3)
|
|
28.899 (63/218) |
9.27E-22 |
Serine/threonine-protein kinase MARK2 (MARK2)
|
|
28.899 (63/218) |
1.14E-21 |
Serine/threonine-protein kinase PAK 5 (PAK5)
|
|
28.829 (64/222) |
1.49E-21 |
BR serine/threonine kinase 2 (BRSK2)
|
|
30.357 (68/224) |
1.65E-21 |
MAP/microtubule affinity-regulating kinase 4 (MARK4)
|
|
27.982 (61/218) |
3.07E-21 |
BR serine/threonine kinase 1 (BRSK1)
|
|
28.099 (68/242) |
5.88E-21 |
Receptor-interacting serine/threonine-protein kinase 3 (RIPK3)
|
|
29.577 (84/284) |
6.21E-21 |
5'-AMP-activated protein kinase catalytic subunit alpha-1 (PRKAA1)
|
|
26.613 (66/248) |
6.79E-21 |
Serine/threonine-protein kinase PAK 6 (PAK6)
|
|
27.016 (67/248) |
7.47E-21 |
Omphalocele kinase 1 (NUAK1)
|
|
28.302 (60/212) |
9.11E-21 |
Serine/threonine-protein kinase NIM1 (NIM1K)
|
|
29.864 (66/221) |
9.67E-21 |
Serine/threonine-protein kinase MARK1 (MARK1)
|
|
28.241 (61/216) |
1.13E-20 |
PAK-4 protein kinase (PAK4)
|
|
27.778 (70/252) |
3.33E-20 |
SIK family kinase 3 (SIK3)
|
|
28.000 (70/250) |
6.26E-20 |
PKC-delta-interacting protein kinase (RIPK4)
|
|
28.470 (80/281) |
8.13E-20 |
Serine/threonine-protein kinase TAO2 (TAOK2)
|
|
30.682 (81/264) |
8.91E-20 |
Serine/threonine-protein kinase Nek5 (NEK5)
|
|
26.459 (68/257) |
9.89E-20 |
NUAK family SNF1-like kinase 2 (NUAK2)
|
|
26.852 (58/216) |
1.54E-19 |
MST-1 protein kinase (STK4)
|
|
27.381 (69/252) |
1.58E-19 |
Serine/threonine-protein kinase Nek3 (NEK3)
|
|
26.613 (66/248) |
1.75E-19 |
Serine/threonine-protein kinase ICK (CILK1)
|
|
31.472 (62/197) |
2.37E-19 |
Mitogen-activated protein kinase kinase kinase 15 (MAP3K15)
|
|
28.000 (70/250) |
4.36E-19 |
Serine/threonine-protein kinase Nek4 (NEK4)
|
|
30.268 (79/261) |
5.46E-19 |
Serine/threonine-protein kinase Nek11 (NEK11)
|
|
25.591 (65/254) |
5.52E-19 |
Protein kinase C delta (PRKCD)
|
|
27.652 (73/264) |
6.45E-19 |
TAO kinase 1 (TAOK1)
|
|
28.731 (77/268) |
9.54E-19 |
TRAF2 and NCK interacting kinase (TNIK)
|
|
28.636 (63/220) |
1.06E-18 |
Ribosomal protein S6 kinase alpha-1 (RSK1)
|
|
25.194 (65/258) |
1.07E-18 |
PAK-2 protein kinase (PAK2)
|
|
28.112 (70/249) |
1.57E-18 |
Aurora kinase C (AURKC)
|
|
24.074 (65/270) |
1.70E-18 |
Ribosomal protein S6 kinase alpha-3 (RSK3)
|
|
26.432 (60/227) |
1.95E-18 |
Ribosomal protein S6 kinase alpha-2 (RSK2)
|
|
26.754 (61/228) |
2.18E-18 |
Ribosomal protein S6 kinase alpha-6 (RSK6)
|
|
24.528 (65/265) |
2.71E-18 |
5'-AMP-activated protein kinase catalytic subunit alpha-2 (PRKAA2)
|
|
25.101 (62/247) |
3.80E-18 |
Protein kinase C alpha (PRKCA)
|
|
26.027 (57/219) |
3.92E-18 |
Serine/threonine-protein kinase 10 (STK10)
|
|
25.461 (69/271) |
4.21E-18 |
Serine/threonine-protein kinase 3 (STK3)
|
|
26.984 (68/252) |
5.40E-18 |
Protein kinase C theta (PRKCQ)
|
|
28.638 (61/213) |
7.27E-18 |
Protein kinase C beta (PRKCB)
|
|
26.027 (57/219) |
8.43E-18 |
Aurora kinase A (AURKA)
|
|
24.231 (63/260) |
1.06E-17 |
TAO kinase 3 (TAOK3)
|
|
28.929 (81/280) |
1.23E-17 |
SPS1/STE20-related protein kinase YSK4 (YSK4)
|
|
28.641 (59/206) |
1.37E-17 |
Myosin light chain kinase 3 (MYLK3)
|
|
29.327 (61/208) |
1.53E-17 |
PAK-1 protein kinase (PAK1)
|
|
26.210 (65/248) |
1.73E-17 |
MAPK/ERK kinase kinase 3 (MAP3K3)
|
|
32.000 (64/200) |
2.48E-17 |
Serine/threonine-protein kinase Nek10 (NEK10)
|
|
25.000 (69/276) |
2.99E-17 |
Leucine-rich repeat kinase 2 (LRRK2)
|
|
26.984 (68/252) |
3.35E-17 |
Serine/threonine-protein kinase 33 (STK33)
|
|
28.000 (63/225) |
4.98E-17 |
Serine/threonine-protein kinase Nek9 (NEK9)
|
|
25.092 (68/271) |
5.06E-17 |
Serine/threonine-protein kinase PAK 3 (PAK3)
|
|
26.923 (56/208) |
6.90E-17 |
Serine/threonine-protein kinase MAK (MAK)
|
|
29.442 (58/197) |
7.96E-17 |
Protein kinase C epsilon (PRKCE)
|
|
27.556 (62/225) |
8.67E-17 |
Cyclin-dependent kinase 3 (CDK3)
|
|
26.855 (76/283) |
9.22E-17 |
STE20-related serine/threonine-protein kinase (SLK)
|
|
26.909 (74/275) |
1.05E-16 |
Myosin light chain kinase 2 (MYLK2)
|
|
26.066 (55/211) |
1.11E-16 |
Aurora kinase B (AURKB)
|
|
24.060 (64/266) |
1.17E-16 |
SNF-related serine/threonine-protein kinase (SNRK)
|
|
24.651 (53/215) |
1.23E-16 |
MAPK/ERK kinase kinase 2 (MAP3K2)
|
|
31.250 (65/208) |
1.28E-16 |
Putative serine/threonine-protein kinase PRKY (PRKY)
|
|
26.267 (57/217) |
1.86E-16 |
Misshapen-like kinase 1 (MINK1)
|
|
27.727 (61/220) |
1.90E-16 |
NIMA-related kinase 7 (NEK7)
|
|
25.592 (54/211) |
2.52E-16 |
Myosin light chain kinase family member 4 (MYLK4)
|
|
27.404 (57/208) |
3.00E-16 |
Hormonally up-regulated neu tumor-associated kinase (HUNK)
|
|
26.601 (54/203) |
3.33E-16 |
Protein kinase C gamma (PRKCG)
|
|
25.417 (61/240) |
3.50E-16 |
Inhibitor of nuclear factor kappa-B kinase alpha (IKKA)
|
|
28.279 (69/244) |
3.91E-16 |
Fused homolog (STK36)
|
|
28.571 (60/210) |
4.08E-16 |
NIMA-related kinase 2 (NEK2)
|
|
27.132 (70/258) |
5.90E-16 |
cAMP-dependent protein kinase catalytic subunit PRKX (PRKX)
|
|
24.701 (62/251) |
6.57E-16 |
Polo-like kinase 4 (PLK4)
|
|
26.238 (53/202) |
7.24E-16 |
Yet another novel kinase 2 (STK32B)
|
|
25.632 (71/277) |
7.52E-16 |
Cyclin-dependent kinase 15 (CDK15)
|
|
27.670 (57/206) |
1.18E-15 |
NIMA-related kinase 6 (NEK6)
|
|
25.121 (52/207) |
1.28E-15 |
NIMA-related kinase 1 (NEK1)
|
|
26.693 (67/251) |
1.37E-15 |
Putative 3-phosphoinositide-dependent protein kinase 2 (PDPK2P)
|
|
27.189 (59/217) |
1.43E-15 |
Cyclin-dependent kinase 1 (CDK1)
|
|
28.814 (68/236) |
1.97E-15 |
Myosin-IIIa (MYO3A)
|
|
24.910 (69/277) |
2.35E-15 |
Nik-related protein kinase (NRK)
|
|
26.263 (78/297) |
2.55E-15 |
Serine/threonine-protein kinase D2 (PRKD2)
|
|
27.650 (60/217) |
3.15E-15 |
Phosphoinositide dependent protein kinase-1 (PDPK1)
|
|
27.189 (59/217) |
3.64E-15 |
MAPK/ERK kinase kinase 4 (MAP3K4)
|
|
24.419 (63/258) |
3.69E-15 |
Calcium/calmodulin-dependent protein kinase type 1G (CAMK1G)
|
|
27.778 (60/216) |
4.23E-15 |
Cyclin-dependent kinase 5 (CDK5)
|
|
28.182 (62/220) |
4.35E-15 |
Maternal embryonic leucine zipper kinase (MELK)
|
|
26.210 (65/248) |
4.56E-15 |
Serine/threonine-protein kinase Chk2 (RAD53)
|
|
28.409 (75/264) |
5.04E-15 |
MAP kinase p38 (MAPK12)
|
|
28.340 (70/247) |
5.58E-15 |
Inhibitor of nuclear factor kappa-B kinase subunit epsilon (IKBKE)
|
|
29.130 (67/230) |
8.07E-15 |
Apoptosis signal-regulating kinase 2 (MAP3K6)
|
|
29.327 (61/208) |
8.66E-15 |
Cyclin-dependent kinase-like 2 (CDKL2)
|
|
25.806 (72/279) |
1.35E-14 |
Apoptosis signal-regulating kinase 1 (MAP3K5)
|
|
25.896 (65/251) |
1.54E-14 |
ERK activator kinase 2 (MEK2)
|
|
28.986 (60/207) |
1.62E-14 |
ERK activator kinase 7 (MAP2K7)
|
|
24.815 (67/270) |
1.73E-14 |
Serine/threonine-protein kinase H1 (PSKH1)
|
|
28.169 (60/213) |
1.78E-14 |
Extracellular signal-regulated kinase 2 (ERK2)
|
|
27.041 (53/196) |
1.80E-14 |
Stress-activated protein kinase 2a (p38 alpha)
|
|
25.991 (59/227) |
1.92E-14 |
Cyclin-dependent kinase 12 (CDK12)
|
|
25.571 (56/219) |
2.02E-14 |
Serine/threonine-protein kinase Nek8 (NEK8)
|
|
25.385 (66/260) |
2.23E-14 |
Serine/threonine-protein kinase NLK (NLK)
|
|
26.941 (59/219) |
2.48E-14 |
Cyclin-dependent kinase 13 (CDK13)
|
|
24.664 (55/223) |
3.15E-14 |
MAPK/ERK kinase kinase 1 (MAP3K1)
|
|
26.941 (59/219) |
3.18E-14 |
Serine/threonine-protein kinase WNK1 (WNK1)
|
|
26.641 (69/259) |
3.22E-14 |
Cyclin-dependent kinase-like 3 (CDKL3)
|
|
28.251 (63/223) |
3.38E-14 |
Tyrosine-protein kinase EIF2AK2 (p68)
|
|
25.267 (71/281) |
3.46E-14 |
Cyclin-dependent kinase 2 (CDK2)
|
|
24.427 (64/262) |
4.77E-14 |
Leucine-rich repeat serine/threonine-protein kinase 1 (LRRK1)
|
|
27.442 (59/215) |
4.97E-14 |
NF-kappa-B-activating kinase (TBK1)
|
|
27.907 (60/215) |
8.48E-14 |
Death-associated protein kinase 2 (DAPK2)
|
|
25.333 (57/225) |
9.61E-14 |
MEK kinase kinase 4 (MAP4K4)
|
|
27.273 (60/220) |
1.05E-13 |
Mitogen-activated protein kinase 15 (MAPK15)
|
|
27.477 (61/222) |
1.07E-13 |
Cyclin-dependent kinase-like 4 (CDKL4)
|
|
25.510 (50/196) |
1.15E-13 |
Cyclin-dependent kinase 9 (CDK9)
|
|
28.019 (58/207) |
1.24E-13 |
Mitogen-activated protein kinase 4 (MAPK4)
|
|
26.848 (69/257) |
1.25E-13 |
Proto-oncogene serine/threonine-protein kinase mos (MOS)
|
|
22.364 (70/313) |
1.43E-13 |
Cyclin-dependent kinase-like 5 (CDKL5)
|
|
26.442 (55/208) |
1.45E-13 |
Unc-51 like kinase 3 (ULK3)
|
|
24.771 (54/218) |
1.48E-13 |
Protein kinase D (PRKD1)
|
|
26.809 (63/235) |
1.49E-13 |
Protein kinase C eta type (PRKCH)
|
|
25.869 (67/259) |
1.54E-13 |
ERK activator kinase 1 (MEK1)
|
|
28.169 (60/213) |
1.55E-13 |
Calcium/calmodulin-dependent protein kinase type 1D (CAMK1D)
|
|
28.169 (60/213) |
1.67E-13 |
Protein kinase G2 (PRKG2)
|
|
25.688 (56/218) |
1.70E-13 |
Protein kinase C zeta (PRKCZ)
|
|
25.854 (53/205) |
1.74E-13 |
Cyclin-dependent kinase 14 (CDK14)
|
|
25.877 (59/228) |
1.74E-13 |
WNK lysine-deficient protein kinase 3 (WNK3)
|
|
25.769 (67/260) |
1.91E-13 |
Stress-activated protein kinase 2b (p38 beta)
|
|
26.957 (62/230) |
2.04E-13 |
Myosin light kinase (MYLK)
|
|
26.794 (56/209) |
2.66E-13 |
Protein kinase N1 (PKN1)
|
|
25.600 (64/250) |
3.00E-13 |
Protein kinase G1 (PRKG1)
|
|
26.316 (60/228) |
3.73E-13 |
Microtubule-associated serine/threonine-protein kinase 2 (MAST2)
|
|
26.582 (63/237) |
3.75E-13 |
Serine/threonine-protein kinase STK11 (STK11)
|
|
27.083 (52/192) |
4.46E-13 |
Serine/threonine-protein kinase SBK1 (SBK1)
|
|
26.190 (55/210) |
4.50E-13 |
Mitogen-activated protein kinase kinase kinase kinase 5 (MAP4K5)
|
|
26.633 (53/199) |
4.53E-13 |
Inhibitor of nuclear factor kappa-B kinase beta (IKKB)
|
|
29.268 (60/205) |
4.91E-13 |
Microtubule-associated serine/threonine-protein kinase 3 (MAST3)
|
|
27.397 (60/219) |
6.87E-13 |
Microtubule-associated serine/threonine-protein kinase 1 (MAST1)
|
|
27.876 (63/226) |
7.36E-13 |
Cyclin-dependent kinase 7 (CDK7)
|
|
26.106 (59/226) |
8.33E-13 |
Doublecortin-like kinase 3 (DCLK3)
|
|
25.366 (52/205) |
8.48E-13 |
Cyclin-dependent kinase-like 1 (CDKL1)
|
|
24.873 (49/197) |
8.72E-13 |
Polo-like kinase 1 (PLK1)
|
|
28.431 (58/204) |
9.31E-13 |
Calcium/calmodulin-dependent protein kinase type 1 (CAMK1)
|
|
28.440 (62/218) |
1.02E-12 |
MEK kinase kinase 3 (MAP4K3)
|
|
26.396 (52/197) |
1.08E-12 |
Calcium/calmodulin-dependent protein kinase type II subunit beta (CAMK2B)
|
|
27.928 (62/222) |
1.13E-12 |
Ribosomal protein S6 kinase beta-2 (RPS6KB2)
|
|
25.556 (46/180) |
1.13E-12 |
Serine/threonine-protein kinase Sgk1 (SGK1)
|
|
24.771 (54/218) |
1.27E-12 |
Testis-specific serine/threonine-protein kinase 1 (TSSK1B)
|
|
25.185 (68/270) |
1.34E-12 |
Death-associated protein kinase 1 (DAPK1)
|
|
25.114 (55/219) |
1.38E-12 |
Extracellular signal-regulated kinase 1 (ERK1)
|
|
24.623 (49/199) |
1.44E-12 |
Mitogen-activated protein kinase 13 (MAPK13)
|
|
26.457 (59/223) |
1.67E-12 |
Serine/threonine-protein kinase 32C (STK32C)
|
|
24.194 (60/248) |
1.76E-12 |
Extracellular signal-regulated kinase 5 (ERK5)
|
|
25.862 (60/232) |
1.93E-12 |
Calcium/calmodulin-dependent protein kinase type 1B (PNCK)
|
|
27.273 (60/220) |
2.00E-12 |
cAMP-dependent protein kinase catalytic subunit beta (PRKACB)
|
|
25.221 (57/226) |
2.15E-12 |
Serine/threonine-protein kinase 32A (STK32A)
|
|
23.894 (54/226) |
2.23E-12 |
cAMP-dependent protein kinase catalytic subunit alpha (PRKACA)
|
|
25.110 (57/227) |
2.27E-12 |
Stress-activated protein kinase JNK2 (JNK2)
|
|
25.943 (55/212) |
2.35E-12 |
Serine/threonine-protein kinase D3 (PRKD3)
|
|
26.577 (59/222) |
2.37E-12 |
Serine/threonine-protein kinase greatwall (MASTL)
|
|
28.289 (43/152) |
2.40E-12 |
Calcium/calmodulin-dependent protein kinase type II subunit gamma (CAMK2G)
|
|
26.606 (58/218) |
2.51E-12 |
RAC-gamma serine/threonine-protein kinase (AKT3)
|
|
24.537 (53/216) |
2.67E-12 |
RAC-beta serine/threonine-protein kinase (AKT2)
|
|
24.537 (53/216) |
2.95E-12 |
Serine/threonine-protein kinase H2 (PSKH2)
|
|
26.695 (63/236) |
3.68E-12 |
Calcium/calmodulin-dependent protein kinase type II subunit delta (CAMK2D)
|
|
27.027 (60/222) |
3.77E-12 |
Testis-specific serine/threonine-protein kinase 4 (TSSK4)
|
|
26.432 (60/227) |
3.83E-12 |
Cyclin-dependent kinase 20 (CDK20)
|
|
24.171 (51/211) |
4.17E-12 |
Serine/threonine-protein kinase MRCK beta (CDC42BPB)
|
|
26.442 (55/208) |
4.36E-12 |
Myotonin-protein kinase (DMPK)
|
|
25.957 (61/235) |
4.92E-12 |
Protein kinase C iota (PRKCI)
|
|
26.341 (54/205) |
4.94E-12 |
Microtubule-associated serine/threonine-protein kinase 4 (MAST4)
|
|
26.606 (58/218) |
5.09E-12 |
Dual specificity mitogen-activated protein kinase kinase 6 (MAP2K6)
|
|
25.850 (76/294) |
5.26E-12 |
Death-associated protein kinase 3 (DAPK3)
|
|
22.374 (49/219) |
6.02E-12 |
MEK kinase kinase 2 (MAP4K2)
|
|
24.631 (50/203) |
6.20E-12 |
Testis-specific serine kinase 2 (TSSK2)
|
|
21.805 (58/266) |
6.81E-12 |
Polo-like kinase 2 (PLK2)
|
|
23.600 (59/250) |
7.37E-12 |
MEK kinase kinase 1 (MAP4K1)
|
|
24.490 (48/196) |
9.71E-12 |
Serine/threonine-protein kinase tousled-like 2 (TLK2)
|
|
30.168 (54/179) |
1.05E-11 |
Cyclin-dependent kinase 4 (CDK4)
|
|
25.123 (51/203) |
1.17E-11 |
Obscurin (OBSCN)
|
|
26.087 (66/253) |
1.31E-11 |
Cyclin-dependent kinase 17 (CDK17)
|
|
24.352 (47/193) |
1.39E-11 |
Dual specificity mitogen-activated protein kinase kinase 3 (MAP2K3)
|
|
25.182 (69/274) |
1.41E-11 |
Stress-activated protein kinase JNK1 (JNK1)
|
|
27.586 (56/203) |
1.46E-11 |
Ribosomal protein S6 kinase beta-1 (S6K1)
|
|
25.150 (42/167) |
1.49E-11 |
ERK activator kinase 5 (MAP2K5)
|
|
24.312 (53/218) |
1.62E-11 |
CDC42 binding protein kinase alpha (DMPK-like alpha)
|
|
25.000 (52/208) |
1.68E-11 |
Protein kinase N2 (PKN2)
|
|
24.280 (59/243) |
1.76E-11 |
TGF-beta-stimulated factor 1 (STK16)
|
|
22.711 (62/273) |
1.91E-11 |
Serine/threonine-protein kinase Sgk2 (SGK2)
|
|
25.688 (56/218) |
1.99E-11 |
Serine/threonine-protein kinase cot (COT)
|
|
24.400 (61/250) |
2.32E-11 |
Cyclin-dependent kinase 11B (CDK11B)
|
|
25.664 (58/226) |
2.53E-11 |
Stress-activated protein kinase JNK3 (JNK3)
|
|
27.451 (56/204) |
2.54E-11 |
Cyclin-dependent kinase 16 (CDK16)
|
|
23.590 (46/195) |
3.49E-11 |
Calcium/calmodulin-dependent protein kinase type II subunit alpha (CAMK2A)
|
|
26.549 (60/226) |
3.86E-11 |
Serine/threonine-protein kinase WNK2 (WNK2)
|
|
25.651 (69/269) |
3.99E-11 |
cAMP-dependent protein kinase catalytic subunit gamma (PRKACG)
|
|
24.312 (53/218) |
4.13E-11 |
Myosin-IIIb (MYO3B)
|
|
25.688 (56/218) |
4.29E-11 |
Serine/threonine-protein kinase WNK4 (WNK4)
|
|
28.502 (59/207) |
5.18E-11 |
Cyclin-dependent kinase 11A (CDK11A)
|
|
25.676 (57/222) |
5.39E-11 |
Serine/threonine-protein kinase PLK3 (PLK3)
|
|
23.009 (52/226) |
6.48E-11 |
Ribosomal protein S6 kinase alpha-5 (RSK5)
|
|
23.661 (53/224) |
7.13E-11 |
MAPK/MAK/MRK overlapping kinase (MOK)
|
|
25.758 (51/198) |
7.40E-11 |
Mitogen-activated protein kinase 6 (MAPK6)
|
|
26.407 (61/231) |
7.52E-11 |
Cyclin-dependent kinase 6 (CDK6)
|
|
24.752 (50/202) |
8.09E-11 |
Kalirin (KALRN)
|
|
26.214 (54/206) |
8.89E-11 |
NDR2 protein kinase (STK38L)
|
|
22.318 (52/233) |
9.41E-11 |
NDR1 protein kinase (STK38)
|
|
22.747 (53/233) |
1.03E-10 |
Serine/threonine-protein kinase Sgk3 (SGK3)
|
|
25.481 (53/208) |
1.30E-10 |
Glycogen synthase kinase-3 alpha (GSK-3A)
|
|
30.180 (67/222) |
1.48E-10 |
Serine/threonine-protein kinase MRCK gamma (CDC42BPG)
|
|
25.359 (53/209) |
1.80E-10 |
RAC-alpha serine/threonine-protein kinase (AKT1)
|
|
25.000 (56/224) |
1.85E-10 |
Citron Rho-interacting kinase (CIT)
|
|
25.854 (53/205) |
1.91E-10 |
Serine/threonine-protein kinase tousled-like 1 (TLK1)
|
|
30.556 (55/180) |
2.01E-10 |
Ribosomal protein S6 kinase alpha-4 (RPS6KA4)
|
|
24.670 (56/227) |
3.06E-10 |
Titin (TTN)
|
23.318 (52/223) |
3.11E-10 |
Calcium/calmodulin-dependent protein kinase type IV (CAMK4)
|
|
25.610 (42/164) |
3.37E-10 |
Calmodulin-dependent kinase II (CAMKK2)
|
|
29.167 (49/168) |
3.86E-10 |
Serine/threonine-protein kinase 17B (STK17B)
|
|
22.648 (65/287) |
5.00E-10 |
Testis-specific serine/threonine-protein kinase 6 (TSSK6)
|
|
28.767 (63/219) |
6.40E-10 |
Serine/threonine-protein kinase NIK (MAP3K14)
|
|
26.020 (51/196) |
8.85E-10 |
Cyclin-dependent kinase 18 (CDK18)
|
|
23.590 (46/195) |
9.42E-10 |
Rho-associated protein kinase 1 (ROCK1)
|
|
27.094 (55/203) |
1.01E-09 |
Testis-specific serine/threonine-protein kinase 3 (TSSK3)
|
|
27.094 (55/203) |
1.25E-09 |
Phosphorylase kinase testis gamma 2 (PHKG2)
|
|
23.265 (57/245) |
1.29E-09 |
PAS domain-containing serine/threonine-protein kinase (PASK)
|
|
20.392 (52/255) |
1.34E-09 |
Serine/threonine-protein kinase SBK2 (SBK2)
|
|
25.854 (53/205) |
1.51E-09 |
Doublecortin-like kinase 2 (DCLK2)
|
|
25.592 (54/211) |
1.92E-09 |
CaM-kinase IV kinase (CAMKK1)
|
|
27.607 (45/163) |
2.47E-09 |
Checkpoint kinase-1 (CHK1)
|
|
24.155 (50/207) |
3.61E-09 |
Glycogen synthase kinase-3 beta (GSK-3B)
|
|
26.838 (73/272) |
4.34E-09 |
Dual specificity mitogen-activated protein kinase kinase 4 (MAP2K4)
|
|
22.826 (63/276) |
4.59E-09 |
Cyclin-G-associated kinase (GAK)
|
|
23.770 (58/244) |
5.63E-09 |
IL-1 receptor-associated kinase 1 (IRAK1)
|
|
23.529 (48/204) |
5.64E-09 |
Cyclin-dependent kinase 10 (CDK10)
|
|
23.267 (47/202) |
5.80E-09 |
Cytoplasmic DRAK1 (STK17A)
|
|
23.906 (71/297) |
7.31E-09 |
STE20-related kinase adapter protein alpha (STRADA)
|
|
25.773 (50/194) |
7.37E-09 |
MAPK-activated protein kinase 2 (MAPKAPK2)
|
|
28.758 (44/153) |
9.41E-09 |
G protein-coupled receptor kinase 5 (GRK5)
|
|
25.373 (51/201) |
1.04E-08 |
Rho-associated protein kinase 2 (ROCK2)
|
|
26.601 (54/203) |
1.13E-08 |
MAPK-activated protein kinase 3 (MAPKAPK3)
|
|
26.144 (40/153) |
1.45E-08 |
Rhodopsin kinase GRK1 (GRK1)
|
|
27.160 (44/162) |
1.51E-08 |
Protein kinase N3 (PKN3)
|
|
25.943 (55/212) |
1.74E-08 |
Serine/threonine-protein kinase 35 (STK35)
|
|
24.803 (63/254) |
1.83E-08 |
Serine/threonine-protein kinase PRP4 homolog (PRPF4B)
|
|
26.190 (55/210) |
1.96E-08 |
G protein-coupled receptor kinase 6 (GRK6)
|
|
23.750 (38/160) |
2.21E-08 |
Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform (PHKG1)
|
|
24.167 (58/240) |
4.32E-08 |
PIM-3 protein kinase (PIM3)
|
|
24.299 (52/214) |
5.11E-08 |
Activin receptor type IB (ACVR1B)
|
|
24.155 (50/207) |
6.69E-08 |
Bone morphogenetic protein receptor (BMPR2)
|
|
23.692 (77/325) |
7.04E-08 |
STE20-related kinase adapter protein beta (STRADB)
|
|
24.255 (57/235) |
9.13E-08 |
Doublecortin-like kinase 1 (DCLK1)
|
|
24.402 (51/209) |
9.59E-08 |
Serine/threonine-protein kinase ULK4 (ULK4)
|
|
24.561 (56/228) |
1.04E-07 |
Cyclin-dependent kinase 19 (CDK19)
|
|
23.671 (49/207) |
1.28E-07 |
Ribosomal protein S6 kinase-related protein (RSKR)
|
|
30.392 (31/102) |
1.32E-07 |
G protein-coupled receptor kinase 4 (GRK4)
|
|
25.786 (41/159) |
1.56E-07 |
Dual specificity protein kinase TTK (MPS1)
|
|
24.820 (69/278) |
1.80E-07 |
PRKR-like endoplasmic reticulum kinase (PERK)
|
|
27.027 (30/111) |
2.41E-07 |
Eukaryotic translation initiation factor 2-alpha kinase 1 (EIF2AK1)
|
|
29.126 (30/103) |
2.71E-07 |
Striated muscle preferentially expressed protein kinase (SPEG)
|
|
22.422 (50/223) |
3.08E-07 |
TBC domain-containing protein kinase-like protein (TBCK)
|
|
21.702 (51/235) |
4.49E-07 |
TGF-beta receptor type I (TGFBR1)
|
|
23.585 (50/212) |
5.63E-07 |
Serine/threonine-protein kinase LATS1 (LATS1)
|
|
21.111 (57/270) |
1.03E-06 |
Cyclin-dependent kinase 8 (CDK8)
|
|
22.816 (47/206) |
1.13E-06 |
Homeodomain-interacting protein kinase 4 (HIPK4)
|
|
25.000 (58/232) |
1.33E-06 |
Homeodomain-interacting protein kinase 3 (HIPK3)
|
|
26.020 (51/196) |
1.49E-06 |
Serine/threonine-protein kinase PDIK1L (PDIK1L)
|
|
22.581 (56/248) |
1.64E-06 |
Dual-specificity tyrosine-phosphorylation regulated kinase 3 (DYRK3)
|
|
24.747 (49/198) |
1.92E-06 |
IL-1 receptor-associated kinase 3 (IRAK3)
|
|
20.994 (38/181) |
1.93E-06 |
Large tumor suppressor homolog 2 (LATS2)
|
|
22.500 (36/160) |
2.63E-06 |
PDZ binding kinase (PBK)
|
|
21.329 (61/286) |
4.14E-06 |
Dual-specificity tyrosine-phosphorylation regulated kinase 2 (DYRK2)
|
|
23.208 (68/293) |
8.23E-06 |
Homeodomain interacting protein kinase 2 (HIPK2)
|
|
25.381 (50/197) |
1.00E-05 |
Serine/threonine kinase-like domain-containing protein STKLD1 (STKLD1)
|
|
23.636 (52/220) |
1.40E-05 |
MAP kinase signal-integrating kinase 2 (MKNK2)
|
|
26.712 (39/146) |
1.48E-05 |
Eukaryotic translation initiation factor 2-alpha kinase 4 (EIF2AK4)
|
|
28.671 (41/143) |
1.48E-05 |
Interleukin-1 receptor-associated kinase-like 2 (IRAK2)
|
|
20.792 (42/202) |
1.93E-05 |
Dual-specificity tyrosine-phosphorylation regulated kinase 1B (DYRK1B)
|
|
25.000 (59/236) |
1.99E-05 |
Homeodomain-interacting protein kinase 1 (HIPK1)
|
|
27.041 (53/196) |
2.62E-05 |
Serine/threonine-protein kinase Kist (UHMK1)
|
|
26.012 (45/173) |
3.19E-05 |
Anti-mullerian hormone II receptor (AMHR2)
|
|
21.242 (65/306) |
3.30E-05 |
Ribonuclease L (RNASEL)
|
|
26.267 (57/217) |
6.83E-05 |
CaM kinase-like vesicle-associated protein (CAMKV)
|
|
24.224 (39/161) |
7.20E-05 |
CDC-like kinase 3 (CLK3)
|
|
22.311 (56/251) |
1.16E-04 |
CDC-like kinase 1 (CLK1)
|
|
25.620 (62/242) |
1.49E-04 |
CDC-like kinase 4 (CLK4)
|
|
23.950 (57/238) |
1.54E-04 |
SH3 and cysteine-rich domain-containing protein 2 (STAC2)
|
|
39.216 (20/51) |
2.69E-04 |
Tau-tubulin kinase 2 (TTBK2)
|
|
22.047 (56/254) |
3.10E-04 |
Activin receptor type IIB (ACVR2B)
|
|
20.678 (61/295) |
4.33E-04 |
Tribbles homolog 1 (TRIB1)
|
|
22.613 (45/199) |
4.70E-04 |
Activin receptor type IIA (ACVR2A)
|
|
19.655 (57/290) |
5.16E-04 |
Wee1-like protein kinase (WEE1)
|
|
24.126 (69/286) |
6.21E-04 |
Dual-specificity tyrosine-phosphorylation regulated kinase 4 (DYRK4)
|
|
24.365 (48/197) |
6.22E-04 |
MAPK-activated protein kinase 5 (MAPKAPK5)
|
|
24.868 (47/189) |
7.68E-04 |
CDC-like kinase 2 (CLK2)
|
|
24.609 (63/256) |
8.72E-04 |
BMP-2-inducible protein kinase (BMP2K)
|
|
23.451 (53/226) |
1.00E-03 |
SH3 and cysteine-rich domain-containing protein (STAC)
|
|
39.216 (20/51) |
1.00E-03 |
Dual-specificity tyrosine-phosphorylation regulated kinase 1A (DYRK1A)
|
|
25.306 (62/245) |
2.00E-03 |
Ribosomal protein S6 kinase-like 1 (RPS6KL1)
|
|
24.561 (28/114) |
2.00E-03 |
Adaptor-associated kinase 1 (AAK1)
|
|
26.531 (39/147) |
3.00E-03 |
Click to Show/Hide the Information of Human Similarity Proteins |